Comments
Drug firm Lupin on Friday said it has launched Arformoterol Tartrate, an inhalation product to treat conditions like chronic bronchitis and emphysema, in the US market.
The Mumbai-based company's product is the generic version of Sunovion Pharmaceuticals Inc's Brovana inhalation solution, Lupin said in a statement.
Also read: Lupin to enter digital healthcare space in India
Arformoterol Tartrate inhalation solution is indicated for the long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
It is for use by nebulisation only, the drugmaker noted.
Shares of Lupin were trading 0.39 per cent up at ₹1,237.20 apiece on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.